Treatment Options For Ankylosing Spondylitis - MySport

Healio: Q&A: A deep dive into the treatment of axial spondyloarthritis, ankylosing spondylitis Q&A: A deep dive into the treatment of axial spondyloarthritis, ankylosing spondylitis Nasdaq: UCB : Five-year Data On Bimekizumab In Treatment Of Ankylosing Spondylitis Shows Improvements UCB : Five-year Data On Bimekizumab In Treatment Of Ankylosing Spondylitis Shows Improvements Treatment for ankylosing spondylitis (AS) aims to achieve and maintain remission. When in remission, disease activity such as inflammation, joint stiffness, and pain is low or minimal. AS is a type of ...

Nasdaq: UCB Announces U.S. FDA Approvals for BIMZELX® (bimekizumab-bkzx) for the Treatment of Psoriatic Arthritis, Non-Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis UCB Announces U.S. FDA Approvals for BIMZELX® (bimekizumab-bkzx) for the Treatment of Psoriatic Arthritis, Non-Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis The American Journal of Managed Care: Bimekizumab Shows Long-Term Efficacy in Nonradiographic AxSpA, Ankylosing Spondylitis